Fermenta Biotech has commissioned a new facility to manufacture Fortified Rice Kernel (FRK) located in Pennepalli, Tirupati district, Andhra Pradesh. With this, the company has entered the rice fortification market and bolstered its emerging portfolio in nutrition. The FRK produced will be enriched with iron, Vitamin B12 and folic acid, in compliance with the Food Safety and Standards Authority of India (FSSAI) guidelines for rice fortification, a company statement notified.
The government needs to set up a separate ministry for the pharma sector to encourage domestic producers and decrease Chinese imports, opined CEOs while participating in a discussion on the challenges being faced by the sector.
This development follows FBL’s announcement of filing patents for its novel technology for synthesizing Molnupiravir in April 2021
Fermenta Biotech Limited (FBL) announced that it has signed a definitive agreement with Aurigene Pharmaceutical Services Limited (APSL), a stepdown subsidiary of Dr Reddy’s Laboratories Limited (DRL). In this arrangement, FBL will exclusively license its proprietary biocatalytic technology for synthesis of molnupiravir and supply its enzyme Candida Antarctica B Lipase (CAL B) to APSL, and APSL will exclusively procure the enzyme from FBL.
For the second consecutive year, Fermenta Biotech Limited has donated vitamin D for the benefit of Maharashtra police personnel, as part of its initiative “Help Protect Our Protectors”. 2,00,000 members of the police force benefitted from the activity and were supplied with vitamin D3 capsules (DV 60K).
Fermenta Biotech Limited (FBL) has developed and also filed patent application(s) for novel biocatalytic technology of manufacturing molnupiravir.